Could less be more? new study tests lower antibiotic dose for pneumonia

NCT ID NCT07537413

First seen May 02, 2026 · Last updated May 15, 2026 · Updated 3 times

Summary

This study looks at whether a lower dose (1 gram daily) of the antibiotic ceftriaxone works as well as the standard higher dose (2 grams daily) for adults hospitalized with pneumonia but not in the ICU. The goal is to see if the lower dose leads to fewer side effects while still curing the infection. About 430 participants will be randomly assigned to one of the two doses.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMMUNITY-ACQUIRED PNEUMONIA (CAP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Maryland Medical Center

    Baltimore, Maryland, 21201, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Maryland Medical Center - Midtown Campus

    Baltimore, Maryland, 21201, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.